These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20717006)

  • 21. [Thrombolytic therapy in acute myocardial infarct].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(16):484-7. PubMed ID: 2340565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial infarction in a young man due to coronary artery aneurysms after an undiagnosed Kawasaki disease.
    Mirza SJ; Mohammed KO; Baslaib FO
    J Emerg Med; 2014 Jun; 46(6):763-6. PubMed ID: 24565879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
    Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
    Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists.
    Willerson JT; Golino P; McNatt J; Eidt J; Yao SK; Buja LM
    Mol Biol Med; 1991 Apr; 8(2):235-43. PubMed ID: 1806765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].
    Calabri GB; Falcini F; Favilli S; Pollini I; Capuzzo L; Simonini G; De Simone L
    Pediatr Med Chir; 2002; 24(5):352-7; discussion 397-9. PubMed ID: 12494535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intracoronary tissue-type plasminogen activator treatment in kawasaki disease and acute myocardial infarction.
    Nakagawa M; Watanabe N; Okuno M; Okamoto N; Fujino H
    Cardiology; 2000; 94(1):52-7. PubMed ID: 11111145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
    Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
    Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful intravenous streptokinase treatment of a child with Kawasaki disease complicated by acute myocardial infarction.
    Liang CD; Huang SC; Su WJ; Chen HY; Lee CH
    Cathet Cardiovasc Diagn; 1995 Jun; 35(2):139-45. PubMed ID: 7656308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy in Kawasaki disease: a report of four cases.
    Harada M; Akimoto K; Otaka M; Sato K; Oda H; Otsuki M; Takahashi K; Kishiro M; Shimizu T
    Pediatr Int; 2013 Oct; 55(5):e111-5. PubMed ID: 24134762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kawasaki disease: a case report and overview of symptoms, signs, investigations and treatment.
    Almeida B; Gleeson P; Chawla K; Brogan P
    Br J Hosp Med (Lond); 2012 Feb; 73(2):C26-8. PubMed ID: 22504712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful thrombolytic therapy using tissue-type plasminogen activator in Kawasaki disease.
    Tsubata S; Ichida F; Hamamichi Y; Miyazaki A; Hashimoto I; Okada T
    Pediatr Cardiol; 1995; 16(4):186-9. PubMed ID: 7567665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful revascularization by pulse infusion thrombolysis in a patient with Kawasaki disease combined with acute myocardial infarction.
    Inaba S; Higaki T; Nagashima M; Nishimura K; Ogimoto A; Higaki J; Okayama H
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1091-2. PubMed ID: 20965471
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease.
    Horigome H; Sekijima T; Miyamoto T
    Heart; 1997 Nov; 78(5):517-8. PubMed ID: 9415017
    [No Abstract]   [Full Text] [Related]  

  • 34. National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease.
    Harada M; Akimoto K; Ogawa S; Kato H; Nakamura Y; Hamaoka K; Saji T; Shimizu T; Kato T
    Pediatr Int; 2013 Dec; 55(6):690-5. PubMed ID: 23919576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient Q-waves in an infant with asymptomatic myocardial infarction due to Kawasaki disease.
    Akagawa D; Motoki N; Hachiya A; Akazawa Y
    Cardiol Young; 2019 Feb; 29(2):231-234. PubMed ID: 30520707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular and the other complication followed with Kawasaki disease].
    Soga T; Uemura S
    Nihon Rinsho; 2008 Feb; 66(2):289-95. PubMed ID: 18260327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose i.v. urokinase for coronary thrombosis in Kawasaki disease.
    Serizawa H; Lin L; Sato T; Takahashi-Igari M; Kato Y
    Pediatr Int; 2019 Mar; 61(3):302-303. PubMed ID: 30854729
    [No Abstract]   [Full Text] [Related]  

  • 38. Missed Kawasaki disease in childhood presenting as myocardial infarction in adults.
    Bhagwat A; Mukhedkar S; Ekbote S; Gordon JB
    Indian Heart J; 2015; 67(4):385-8. PubMed ID: 26304576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myocardial infarction in infants and children].
    Isaka N
    Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():147-52. PubMed ID: 17952987
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of Myocardial Infarction in Children with Giant Coronary Artery Aneurysms after Kawasaki Disease.
    Burns JC; El-Said H; Tremoulet AH; Friedman K; Gordon JB; Newburger JW
    J Pediatr; 2020 Jun; 221():230-234. PubMed ID: 32312552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.